Prognostic Role of Beta‐2 Microglobulin in Diffuse Large B‐Cell Lymphoma: Systematic Review and Meta‐Analysis of Observational Studies
The available evidence suggests that β2M serves as an independent prognostic marker with significant effects on OS and PFS in DLBCL patients. Elevated serum β2M levels are associated with poor prognosis and worse OS and PFS outcomes in DLBCL patients.
Authors
- Hamideh Feiz Disfani (ORCID: https://orcid.org/0000-0003-4554-9008)
- Kazem Rahmani (ORCID: https://orcid.org/0000-0002-6940-7947)
- Mostafa Kamandi (ORCID: https://orcid.org/0000-0003-4030-3850)
- Rasoul Shavaleh (ORCID: https://orcid.org/0000-0003-4171-6294)
- Moloud Foogerdi (ORCID: https://orcid.org/0000-0002-5476-4001)
- Mahsan Ramezani (ORCID: https://orcid.org/0000-0002-8362-979X)
- Maysam Moradi (ORCID: https://orcid.org/0000-0002-9060-0688)
- Vajiheh Sadat Saghi (ORCID: https://orcid.org/0009-0002-0806-2559)
Institutions
- University of Neyshabur (IR)
- Iran University of Medical Sciences (IR)
- Mashhad University of Medical Sciences (IR)
- Torbat Heydarieh University of Medical Sciences (IR)
- Kermanshah University of Medical Sciences (IR)
- University of Torbat Heydarieh (IR)
- Birjand University of Medical Sciences (IR)
Publication Details
- Journal
- Cancer Reports
- Published
- 2025-11-29
- DOI
- https://doi.org/10.1002/cnr2.70416
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00